![]() |
CZECH MEDICAL ASSOCIATION J. Ev. PURKYNĚ |
Journals - Article | |
![]() |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
Česky / Czech version | Trans. Hemat. dnes, 10, 2004, No. 3, p. 112–113. |
The succesfull treatment of follicular lymphoma
relaps performed by 90Y Ibritumomab tiuxetan (Zevalin) Slabý J.1, Kozák T.1, Bělohlávek O.2, Lang O.3 1Oddělení klinické hematologie, FNKV, Praha, 2PET centrum, Nemocnice Na Homolce, Praha, 3Oddělení nukleární medicíny, FNKV, Praha |
|
Summary: Radioimmunotherapy represents the other step in specific anti-tumor therapy. 57-years old woman
received Ytrium 90 ibritumomab tiuxetan (Zevalin) as a treatment of relaps of follicular lymphoma.
Treatment was tolerated very well; it was followed by uncomplicated trombocytopenia (Gr. 3, WHO
classification) andneutropenia (Gr. 2,WHOclassification).PET-CT evaluationperformed after finishing
of treatment revealed achievement of complete remission.
|
|
Order this issue
|
BACK TO CONTENTS | ||
| HOME PAGE | CODE PAGE | CZECH VERSION | |
© 1998 - 2008 CZECH MEDICAL ASSOCIATION J. E. PURKYNĚ |
Created by: NT Servis, s.r.o., hosted by P.E.S. consulting, s.r.o. |
WEBMASTER |